These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 1740506)

  • 1. Reduction in size of a thyrotropin- and gonadotropin-secreting pituitary adenoma treated with octreotide acetate (somatostatin analog).
    Sy RA; Bernstein R; Chynn KY; Kourides IA
    J Clin Endocrinol Metab; 1992 Mar; 74(3):690-4. PubMed ID: 1740506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of the long-acting octreotide formulation (octreotide-LAR) in patients with thyrotropin-secreting pituitary adenomas.
    Caron P; Arlot S; Bauters C; Chanson P; Kuhn JM; Pugeat M; Marechaud R; Teutsch C; Vidal E; Sassano P
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2849-53. PubMed ID: 11397898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long term treatment with the somatostatin analog SMS 201-995 in a patient with a thyrotropin- and growth hormone-secreting pituitary adenoma.
    Wémeau JL; Dewailly D; Leroy R; D'Herbomez M; Mazzuca M; Decoulx M; Jaquet P
    J Clin Endocrinol Metab; 1988 Mar; 66(3):636-9. PubMed ID: 2895119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term preoperative management of thyrotropin-secreting pituitary adenoma with octreotide.
    Iglesias P; Díez JJ
    J Endocrinol Invest; 1998 Dec; 21(11):775-8. PubMed ID: 9972679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of octreotide acetate on thyrotropin-secreting adenoma: report of two cases and review of the literature.
    Yoenem A; Cakyr B; Azal O; Corakcy A; Kutlu M; Oezata M
    Endocr Regul; 1999 Dec; 33(4):169-74. PubMed ID: 10700085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction in size of a thyrotropin-secreting pituitary adenoma treated with octreotide acetate (somatostatin analog).
    Lee EJ; Kim KR; Lim SK; Lee HC; Kim DI; Kim SH; Huh KB
    Eur J Endocrinol; 1994 Jul; 131(1):109-12. PubMed ID: 8038902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful pregnancy in an infertile woman with a thyrotropin-secreting macroadenoma treated with somatostatin analog (octreotide).
    Caron P; Gerbeau C; Pradayrol L; Simonetta C; Bayard F
    J Clin Endocrinol Metab; 1996 Mar; 81(3):1164-8. PubMed ID: 8772594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the treatment of thyrotropin-secreting pituitary adenomas with a slow release formulation of the somatostatin analog lanreotide.
    Kuhn JM; Arlot S; Lefebvre H; Caron P; Cortet-Rudelli C; Archambaud F; Chanson P; Tabarin A; Goth MI; Blumberg J; Catus F; Ispas S; Beck-Peccoz P
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1487-91. PubMed ID: 10770186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of hyperthyroidism due to inappropriate secretion of thyrotropin with the somatostatin analog SMS 201-995.
    Beck-Peccoz P; Mariotti S; Guillausseau PJ; Medri G; Piscitelli G; Bertoli A; Barbarino A; Rondena M; Chanson P; Pinchera A
    J Clin Endocrinol Metab; 1989 Jan; 68(1):208-14. PubMed ID: 2491862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative octreotide treatment of growth hormone-secreting and clinically nonfunctioning pituitary macroadenomas: effect on tumor volume and lack of correlation with immunohistochemistry and somatostatin receptor scintigraphy.
    Plöckinger U; Reichel M; Fett U; Saeger W; Quabbe HJ
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1416-23. PubMed ID: 7962337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gonadotropin and alpha-subunit responses to chronic gonadotropin-releasing hormone analog administration in patients with glycoprotein hormone-secreting pituitary tumors.
    Klibanski A; Jameson JL; Biller BM; Crowley WF; Zervas NT; Rivier J; Vale WW; Bikkal H
    J Clin Endocrinol Metab; 1989 Jan; 68(1):81-6. PubMed ID: 2535852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TSH producing pituitary tumor: biochemical diagnosis and long-term medical management with octreotide.
    Chayen SD; Gross D; Makhoul O; Glaser B
    Horm Metab Res; 1992 Jan; 24(1):34-8. PubMed ID: 1612557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative long-acting octreotide treatment for invasive thyrotropin-secreting pituitary macroadenoma after previous radioiodine thyroid ablation.
    Gruszka A; Zielinski GM; Kunert-Radek J
    J Clin Neurosci; 2014 Feb; 21(2):340-2. PubMed ID: 23958483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary Medical Treatment of Thyrotropin-Secreting Pituitary Adenomas by First-Generation Somatostatin Analogs: A Case Study of Seven Patients.
    Rimareix F; Grunenwald S; Vezzosi D; Rivière LD; Bennet A; Caron P
    Thyroid; 2015 Aug; 25(8):877-82. PubMed ID: 26244412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term preoperative octreotide treatment for TSH-secreting pituitary adenoma.
    Fukuhara N; Horiguchi K; Nishioka H; Suzuki H; Takeshita A; Takeuchi Y; Inoshita N; Yamada S
    Endocr J; 2015; 62(1):21-7. PubMed ID: 25273395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of the long-acting octreotide formulation in patients with thyroid-stimulating hormone-secreting pituitary adenomas after incomplete surgery and octreotide treatment failure.
    Zhang CF; Liang D; Zhong LY
    Chin Med J (Engl); 2012 Aug; 125(15):2758-63. PubMed ID: 22931988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of thyrotropin-releasing hormone test, SMS 201-995, and bromocriptine in the diagnosis and treatment of gonadotropin-secreting pituitary adenomas.
    Blanco C; Lucas T; Alcañiz J; Davila N; Serrano P; Barcelò B; Estrada J
    J Endocrinol Invest; 1994 Feb; 17(2):99-104. PubMed ID: 8006339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic somatostatin analog administration in patients with alpha-subunit-secreting pituitary tumors.
    Katznelson L; Oppenheim DS; Coughlin JF; Kliman B; Schoenfeld DA; Klibanski A
    J Clin Endocrinol Metab; 1992 Nov; 75(5):1318-25. PubMed ID: 1358910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocrine, biochemical, and morphological studies of a pituitary adenoma secreting growth hormone, thyrotropin (TSH), and alpha-subunit: evidence for secretion of TSH with increased bioactivity.
    Beck-Peccoz P; Piscitelli G; Amr S; Ballabio M; Bassetti M; Giannattasio G; Spada A; Nissim M; Weintraub BD; Faglia G
    J Clin Endocrinol Metab; 1986 Apr; 62(4):704-11. PubMed ID: 2419356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a slow-release formulation of the new somatostatin analogue lanreotide in TSH-secreting pituitary adenomas.
    Gancel A; Vuillermet P; Legrand A; Catus F; Thomas F; Kuhn JM
    Clin Endocrinol (Oxf); 1994 Mar; 40(3):421-8. PubMed ID: 8187308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.